Eloxx rugi bersih Q2 FY26 melebar 138% menjadi USD 4,5 juta

Reuters2026/08/11 21:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Eloxx Pharmaceuticals mencatat rugi bersih USD 4,5 juta pada kuartal yang berakhir 30 Juni 2026, melebar 138%.
Beban operasi naik 181% menjadi USD 4,45 juta, dipimpin R&D yang melonjak 216% menjadi USD 2,84 juta.
Untuk semester I, rugi bersih melebar 129% menjadi USD 8,26 juta, sementara kas yang digunakan untuk operasi mencapai USD 10,24 juta.
Kas dan setara kas berjumlah USD 62 juta per 30 Juni 2026, setelah penawaran umum menghasilkan dana bersih USD 58,3 juta.
Eloxx menargetkan memulai uji klinis Phase 2b exaluren pada kuartal III 2026, menyusul izin melanjutkan dari FDA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-344964), on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Eloxx rugi bersih Q2 FY26 melebar 138% menjadi USD 4,5 juta

You may also like

Crypto prices